All the photos on our website are IWMF members.
Dr. Robert Kyle, Professor of Medicine and Laboratory Medicine and Pathology at Mayo Clinic and noted international expert on WM, recently celebrated a landmark 52-year anniversary
AbbVie announced on July 10, 2015, that the European Commission has granted marketing authorization for Imbruvica (ibrutinib) for the treatment of Waldenstrom’s macroglobulinemia.
Select videos from the 2015 IWMF Educational Forum (held in Dallas, Texas, on May 1-3, 2015) are now available.
This website is supported in part by unrestricted educational grants from Gilead Sciences, Inc. ,
Idera Pharmaceuticals , and Onyx Pharmaceuticals, an Amgen subsidiary